Extina Pharmacy Image


With Prestium Pharma's Prescription Savings Program, your patients can save up to $45 off out-of-pocket costs each time their pharmacist fills or refills the prescription. Ask for a supply of Prescription Savings Cards to provide your patients with their script.

The cards are valid at participating pharmacies for one use per medicine per month. Not valid for patients under Medicaid, Medicare (including Medicare Part D), or similar state or federal programs. The card is not valid for residents of Massachusetts unless the patient is paying the full cost of the prescription.

How the Prestium Pharma Combo Savings Card Works for Your Patients:


  • Pay the initial $15, you could recieve up to $45 off your co-pay or out-of-pocket expenses.

  • You may pay more than $15 if your co-pay exceeds $60; if your insurance does not cover Denavir, Elimite, Evoclin, Extina, Luxiq, Olux, Olux-E or Vusion; or if you are a chase payer.

  • Go to www.PrestiumPharma.com for more information.

  • For assistance with the Prestium Pharma Combo Savings Card, contact 1-855-820-3232.

  • After each transaction, keep this card for up to 12 total uses.



Full Prescribing Information

  • The safety and efficacy of this ketoconazole preparation for the treatment of fungal infections have not been established.

  • Extina® (ketoconazole) Foam, 2% is for topical use only and not for ophthalmic, oral, or intravaginal use. This preparation may be irritating to mucous membranes. Contact with eyes, nostrils, and mouth should be avoided.

  • Use of EXTINA Foam may result in contact sensitization, including photoallerginicity.

  • The most common adverse reactions observed in clinical trials (incidence > 1%) were application site burning (10%) and application site reaction (6%).

  • EXTINA Foam should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.

  • Advise patients who are breastfeeding to exercise caution when applying this product.

  • Hepatitis and, at high doses, lowered testosterone and ACTH-induced corticosteroid serum levels have been seen with orally administered ketoconazole; however, these effects have not been seen with topical formulations.

  • The contents of EXTINA Foam are flammable; patients should avoid fire, flame, and/or smoking during and immediately following application.

EXTINA Foam is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.